Prudential Financial Inc Abbott Laboratories Transaction History

Prudential Financial Inc

$80 Billion
Q3 2025

A detailed history of Prudential Financial Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Prudential Financial Inc holds 1,146,288 shares of ABT stock, worth $149 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

1,146,288

Previous 2,353,356 51.29%

Holding current value

$149 Million

Previous $320 Million 52.03%

% of portfolio

0.19%

Previous 0.43%

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$120.51 - $136.62 $145 Million - $165 Million	-1,207,068 Reduced 51.29%	1,146,288 $154 Million
Q2 2025 Aug 12, 2025	BUY	$123.95 - $138.08 $62.7 Million - $69.9 Million	506,093 Added 27.4%	2,353,356 $320 Million
Q1 2025 May 13, 2025	SELL	$111.1 - $140.22 $57.1 Million - $72 Million	-513,722 Reduced 21.76%	1,847,263 $245 Million
Q4 2024 Feb 11, 2025	SELL	$111.93 - $119.39 $32.6 Million - $34.7 Million	-290,965 Reduced 10.97%	2,360,985 $267 Million
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $11.6 Million - $13.7 Million	115,600 Added 4.56%	2,651,950 $302 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $2.59 Million - $2.89 Million	25,698 Added 1.02%	2,536,350 $264 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $51.7 Million - $57.1 Million	472,131 Added 23.16%	2,510,652 $285 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $50.8 Million - $62.1 Million	-562,820 Reduced 21.64%	2,038,521 $224 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $44.4 Million - $53.3 Million	-464,670 Reduced 15.16%	2,601,341 $252 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $18.6 Million - $20.7 Million	-184,388 Reduced 5.67%	3,066,011 $334 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $36.8 Million - $43.3 Million	379,746 Added 13.23%	3,250,399 $329 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $26.6 Million - $31.2 Million	-279,349 Reduced 8.87%	2,870,653 $0
Q3 2022 Nov 04, 2022	SELL	$96.76 - $112.03 $23.5 Million - $27.2 Million	-242,705 Reduced 7.15%	3,150,002 $305 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $1.79 Million - $2.16 Million	17,488 Added 0.52%	3,392,707 $369 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $82.4 Million - $100 Million	722,417 Added 27.23%	3,375,219 $399 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $18.8 Million - $23 Million	162,580 Added 6.53%	2,652,802 $373 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $103 Million - $114 Million	-886,454 Reduced 26.25%	2,490,222 $294 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $41.9 Million - $49.3 Million	-396,021 Reduced 10.5%	3,376,676 $391 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $9.65 Million - $11.4 Million	88,683 Added 2.41%	3,772,697 $452 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $385 Million - $420 Million	3,668,769 Added 24065.39%	3,684,014 $403 Million
Q3 2020 Aug 05, 2021	SELL	$91.64 - $111.29 $345 Million - $419 Million	-3,762,250 Reduced 99.6%	15,245 $1.66 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $345 Million - $419 Million	3,766,646 Added 34718.83%	3,777,495 $411 Million
Q2 2020 Aug 05, 2021	SELL	$76.57 - $98.0 $265 Million - $339 Million	-3,457,105 Reduced 99.69%	10,849 $992,000
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $265 Million - $339 Million	3,462,595 Added 64612.71%	3,467,954 $317 Million
Q1 2020 Aug 05, 2021	SELL	$62.82 - $91.86 $117 Million - $170 Million	-1,855,140 Reduced 99.71%	5,359 $423,000
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $116 Million - $170 Million	1,854,124 Added 29084.3%	1,860,499 $147 Million
Q4 2019 Aug 05, 2021	SELL	$78.51 - $87.4 $144 Million - $160 Million	-1,834,017 Reduced 99.65%	6,375 $554,000
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $144 Million - $160 Million	1,834,791 Added 32758.28%	1,840,392 $160 Million
Q3 2019 Aug 05, 2021	SELL	$81.84 - $88.74 $160 Million - $173 Million	-1,950,496 Reduced 99.71%	5,601 $469,000
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $160 Million - $173 Million	1,951,429 Added 41804.39%	1,956,097 $164 Million
Q2 2019 Aug 05, 2021	SELL	$72.88 - $85.0 $250 Million - $291 Million	-3,425,339 Reduced 99.86%	4,668 $393,000
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $250 Million - $291 Million	3,425,612 Added 77943.39%	3,430,007 $0
Q1 2019 Aug 05, 2021	SELL	$66.22 - $80.06 $208 Million - $251 Million	-3,136,242 Reduced 99.86%	4,395 $351,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $208 Million - $251 Million	3,136,968 Added 85499.26%	3,140,637 $0
Q4 2018 Aug 05, 2021	SELL	$65.56 - $74.27 $168 Million - $190 Million	-2,555,162 Reduced 99.86%	3,669 $265,000
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $168 Million - $190 Million	2,557,977 Added 299528.91%	2,558,831 $185 Million
Q3 2018 Sep 01, 2021	SELL	$60.81 - $73.36 $339 Million - $409 Million	-5,569,059 Reduced 99.98%	854 $63,000
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $339 Million - $409 Million	5,569,690 Added 2497618.75%	5,569,913 $0
Q2 2018 Sep 01, 2021	SELL	$57.57 - $63.54 $322 Million - $355 Million	-5,591,310 Reduced 100.0%	223 $14,000
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $322 Million - $355 Million	5,591,505 Added 0.0%	5,591,533 $0
Q1 2018 Sep 01, 2021	SELL	$56.27 - $63.62 $303 Million - $343 Million	-5,386,002 Reduced 100.0%	28 $2,000
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $13.4 Million - $15.2 Million	-238,293 Reduced 4.24%	5,386,030 $0
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $10.3 Million - $11 Million	192,164 Added 3.54%	5,624,323 $321 Million
Q3 2017 Nov 30, 2017	BUY	$48.06 - $53.64 $261 Million - $291 Million	5,432,159	5,432,159 $290 Million

Others Institutions Holding ABT

# of Institutions

3,650

Shares Held

1.38B

Call Options Held

10.4M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Abbott Laboratories Transaction History